When interviewed in Shangkou Village, Shangkou Township, Shouguang City, the reporter discovered that Master Zhang was in the last flower of the ear, but the top of the tomato had no leaves above the spike. This is detrimental to the growth of the upper tomato fruit for the following reasons:
First, it is not conducive to fruit enlargement. According to the theory of source-vegetation for plant growth, the nutrients needed for the enlargement of tomato fruits depend mainly on the supply of the upper leaves closest to the fruit. If the leaves above the top of the tomato are removed, it will result in insufficient nutrient for the blade to manufacture, which can not meet the needs of the growth of the top tomato, resulting in the small upper fruit and poor commercial property.
Second, it is easy to produce sunburn fruit. As the weather gets warmer, the intensity of sunlight becomes stronger. If the upper part of the fruit is not covered by the leaves, the young fruit is exposed to direct sunlight and is easily burned by strong light, resulting in sunburning fruit.
Again, it is not conducive to the turning of fruits. Tomatoes from the end of the flower to the market, it now takes 50-60 days, when the fruit into the color conversion period, the high temperature and light affect the formation of fruit lycopene, resulting in a large number of tomatoes produce green shoulder.
The farmers are reminded to pick up 2-3 leaves at the top of the top of the top of the ear in order to ensure the growth of the nutrient supply of the fruit produced by the leaves, without causing the fruit to produce sun-burning fruit and Green shoulder fruit.
Then, how should the tomatoes that have been removed from the growing point be managed to prevent the occurrence of these conditions? The reporter believes that the vegetable farmers can adopt the method of leaving lateral branches to solve. The vegetable farmer can keep the pods at the leaves of the uppermost leaves and pick them up when the side branches grow to 3-4 leaves.
Intermediates of Cladribine, Carvedilol, Lurasidone, olmesartan,
Risedronate Sodium, Atazanavir, Saxagliptin,
Dabigatran,Dapoxetine,Cefixime,Ceftaroline fosamil and etc.
In the short span of time, we have emerged as most promising
pharmaceutical intermediates manufacturers, chemical intermediates and
bulk drug intermediates suppliers. Our consistent supply, quality
products and dedication towards clients have opened up many
international avenues for our growth.
In addition, the company also can follow the customer's product needs custom synthesis services
MAIN API PRODUCTS USP/BP
|
PRODUCT NAME
|
CAS NUMBER
|
SPEVIFICATION
|
|
Azithromycin
|
117772-70-0
|
BEP
|
|
Cefpirome Sulphate sterile
|
84957-29-9
|
USP JP16
|
|
Ceftriaxone Sodium (Sterile)
|
104376-79-6
|
USP31
|
|
Cefotaxime
|
64485-93-4
|
USP30
|
|
Ciprofloxacin HCL
|
85721-33-1
|
USP/BP
|
|
Gentamicin sulphate
|
1405-41-0
|
BP
|
|
Levofloxacin
|
100986-85-4
|
USP27
|
|
Lincomycin Hydrochloride
|
859-18-7
|
EP6.0
|
|
Moxifloxacin Hydrochloride
|
186826-86-8
|
USP31
|
|
Tigecycline
|
220620-09-7
|
USP
|
|
Linezolid
|
165800-03-3
|
EP
|
|
Dexamethasone
|
50-02-2
|
USP/BP/EP
|
|
Methylprednisolone
|
83-43-2
|
USP/BP/EP
|
|
Dexketoprofen trometamol
|
156604-79-4
|
BP2008
|
|
Ibuprofen
|
15687-27-1
|
BP
|
|
Metamizol
|
68-89-3
|
DAB
|
|
Sulindac
|
38194-50-2
|
USP/BP/EP
|
|
Naproxcinod
|
163133-43-5
|
USP28
|
|
Tripelennamine Hydrochloride
|
154-69-8
|
USP28
|
|
Itraconazole
|
84625-61-6
|
USP/BP
|
|
Cytarabine
|
147-94-4
|
USP31
|
|
Leucovorin Calcium
|
1492-18-8
|
USP32
|
|
Valsartan
|
137862-53-4
|
USP30
|
|
Telmisartan
|
144701-48-4
|
USP31
|
|
Rosuvastatin Calcium
|
147098-20-2
|
USP/BP
|
|
Pitavastatin Calcium
|
147526-32-7
|
USP/BP
|
|
Fluvastatin
|
93957-54-1
|
USP31
|
|
Vinpocetine
|
42971-09-5
|
EP6.0
|
|
Atazanavir
|
198904-31-3
|
BP
|
|
Rosiglitazone
|
122320-73-4
|
USP30
|
|
Esomeprazole Magnesium
|
161973-10-0
|
USP/BP
|
|
Topiramate
|
97240-79-4
|
USP31
|
|
Fexofenadine HCl
|
153439-40-8
|
Inhouse
|
|
Bosentan
|
147536-97-8
|
Inhouse
|
|
D-Cysteine
|
921-01-7
|
Inhouse
|
|
D-Phenylalanine
|
673-06-3
|
Inhouse
|
|
Linagliptin
|
668270-12-0
|
Inhouse
|
|
Rivaroxaban
|
366789-02-8
|
USP
|
|
Saxagliptin
|
361442-04-8
|
USP
|
|
Vildagliptin
|
274901-16-5
|
USP
|
Major Pharmaceutical Intermediates
|
Items Descripation
|
Structure
|
Application
|
MICA ESTER
CAS No: 246035-38-1
Purity: ≥98%
|
|
For Cefixime
|
EHATA
CAS No: 64485-82-1
Purity: ≥98%
|
|
For Ceftazidine
|
2-Chloroadenine
CAS No: 1839-18-5
|
|
For Cladribine, Fludarabine et al
|
Bicyclo(2,2,1)Heptane-2,3-di-exo-carboximide
CAS No: 14805o-29-9
|
|
For Lurasidne
|
(R,R)-1,2-Bis(methanesulfonyloxy methyl)Cyclohexane
CAS No: 186204-35-3
|
|
For Lurasidone
|
3-(Piperazin-1-yl)benzol[d] isothiazole
CAS No: 87691-87-0
|
|
For Lurasidone
|
Trityl olmesartan
CAS No: 144690-92-6
Purity: ≥98%
|
|
For olmesartan
|
3-Acetyl Pyridine
CAS No: 350-03-8
|
|
For Risedronate Sodium
|
3-(AceticAcid)pyridine HCL
CAS No: 6419-36-9
|
|
For Risedronate Sodium
|
Risedronic Acid
CAS No: 105462-24-6
|
|
For Risedronate Sodium
|
3-Hydroxy-1-adamantyl-D-Glycine
CAS No: 709031-29-8
|
|
For Saxagliptin
|
(1s,3s,5s)-3-(aminocarbonyl)-2-azabicyclo(3,1,0) hexane-2-carboxylic acid tert-butyl ester
CAS No: 361440-67-7
|
|
For Saxagliptin
|
(S)-N-Boc-3- hydroxy-adamantylglycine
CAS No: 361442-00-4
|
|
For Saxagliptin
|
2-Azabicyclo[3.1.0] hexane-3-carbonitrile, (1s,3s,5s)-
CAS No: 866083-42-3
|
|
For Saxagliptin
|
Ethyl 3-(pyridin-2-ylamino) propanoate
CAS No: 103041-38-9
|
|
For Dabigatran
|
N-(4-Cyanophenyl) glycine
CAS No: 42288-26-6
|
|
For Dabigatran
|
4-methylamino-3-nitrobenzoic Acid
CAS No: 41263-74-5
|
|
For Dabigatran
|
S-3-Amino-3-phenylpropanoic acid ethyl ester HCL
CAS No: 167834-24-4
|
|
For Dapoxetine
|
(S)-3-Amino-3-Phemylpropan -1-ol
CAS No: 82769-76-4
|
|
For Dapoxetine
|
(S)-3-Dimethylamino-3-Phemylpropanol
CAS No: 82769-75-3
|
|
For Dapoxetine
|
4-{4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-butynil}-α,α-dimethyl benzene acetic acid
CAS No: 832088-68-3
|
|
For Fexofenadine HCl
|
Methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate
CAS No:154477-54-0
|
|
For Fexofenadine HCl
|
5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
CAS No 461432-22-4
|
|
For Dapagliflozin
|
4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether
CAS No :461432-23-5
|
|
For Dapagliflozin
|
APIs & Intermediates
Mica Ester,Pharma Intermediates,Ciprofloxacin Hcl Uses,Active Pharmaceutical Ingredients
NINGBO VOICE BIOCHEMIC CO. LTD , https://www.pharma-voice.com